STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 70 filers reported holding STEMLINE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 2.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $115,000 | -0.9% | 10,702 | 0.0% | 0.01% | +14.3% |
| Q3 2016 | $116,000 | -78.2% | 10,702 | -86.4% | 0.01% | -81.1% |
| Q2 2016 | $532,000 | +45.4% | 78,603 | 0.0% | 0.04% | +15.6% |
| Q1 2016 | $366,000 | -26.2% | 78,603 | 0.0% | 0.03% | -13.5% |
| Q4 2015 | $496,000 | -64.3% | 78,603 | -50.0% | 0.04% | -32.7% |
| Q3 2015 | $1,388,000 | +48.8% | 157,206 | +98.4% | 0.06% | -1.8% |
| Q2 2015 | $933,000 | -18.7% | 79,245 | 0.0% | 0.06% | -37.1% |
| Q1 2015 | $1,147,000 | +114600.0% | 79,245 | +208439.5% | 0.09% | – |
| Q1 2014 | $1,000 | 0.0% | 38 | 0.0% | 0.00% | – |
| Q4 2013 | $1,000 | -100.0% | 38 | -100.0% | 0.00% | -100.0% |
| Q3 2013 | $8,172,000 | -42.1% | 180,416 | -69.5% | 0.34% | -76.4% |
| Q2 2013 | $14,105,000 | – | 591,650 | – | 1.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 835,245 | $8,695,000 | 4.02% |
| Rubric Capital Management LP | 2,582,433 | $26,883,000 | 2.46% |
| Clearline Capital LP | 306,765 | $3,193,000 | 1.46% |
| Eventide Asset Management | 4,160,608 | $43,312,000 | 1.43% |
| SECTORAL ASSET MANAGEMENT INC | 677,759 | $7,055,000 | 1.22% |
| Telemetry Investments, L.L.C. | 40,000 | $416,000 | 1.20% |
| Rhenman & Partners Asset Management AB | 511,023 | $5,320,000 | 0.67% |
| HealthCor Management, L.P. | 1,243,780 | $12,948,000 | 0.49% |
| KNOTT DAVID M | 107,934 | $1,124,000 | 0.47% |
| Empire Life Investments Inc. | 514,269 | $5,354,000 | 0.45% |